Polypharmacy in Older Adults: The Role of the Advanced Practitioner in Oncology
Diane G. Cope, PhD, ARNP, BC, AOCNP®
From Florida Cancer Specialists and Research Institute, Fort Myers, Florida
The author has no conflicts of interest to disclose.
Correspondence to: Diane G. Cope, PhD, ARNP, BC, AOCNP®, 15681 New Hampshire Court, Fort Myers, FL 33919. E-mail: firstname.lastname@example.org
J Adv Pract Oncol 2013;4:107–112 |
DOI: 10.6004/jadpro.2013.4.2.5 |
© 2013 Harborside Press®
As Americans age, health-care providers will be faced with new and challenging issues related to the care of older adults. One critical issue unique to the aging population is polypharmacy. Cancer-related medications can add to the complexity of this issue. As oncology APs, we are perfectly positioned to assess and manage our patients’ pharmaceutical agents to help avoid this very serious health threat.
For access to the full length article, please sign in